The usefulness of fluorine-18 fluorodeoxyglucose PET in the detection of recurrence in patients with differentiated thyroid cancer with elevated thyroglobulin and negative radioiodine whole-body scan
Authors:
- Jaroslaw KaznowskiJKJaroslaw Kaznowski
- Kosma WolinskiKWKosma Wolinski
- Elzbieta JodlowskaEJElzbieta Jodlowska
- Piotr MichaliszynPMPiotr Michaliszyn
- Katarzyna KubiakKKKatarzyna Kubiak
- Rafal CzepczynskiRCRafal Czepczynski
- Marek RuchalaMRMarek Ruchala
- 1 September 2016
- journal article
- Published by Wolters Kluwer Health in Nuclear Medicine Communications
- Vol. 37 (9) , 935-938
Abstract
PET/CT is a useful tool in the detection of recurrence among thyroid cancer patients in cases of conflicting results of standard procedures, particularly for those with high Tg levels and negative WBS. The probability of obtaining a positive PET-CT result increases with the level of Tg.Keywords
This publication has 15 references indexed in Scilit:
- Fluorodeoxyglucose positron emission tomography/computerized tomography in differentiated thyroid cancer management: Importance of clinical justification and value in predicting survivalJournal of Medical Imaging and Radiation Oncology, 2015
- The Usefulness of Standardized Uptake Value in Differentiation between Benign and Malignant Thyroid Lesions Detected Incidentally in 18F-FDG PET/CT ExaminationPLOS ONE, 2014
- Jak typować guzy do biopsji aspiracyjnej cienkoigłowej w wolu wieloguzkowym? Rola konwencjonalnej ultrasonografii oraz elastografii fali poprzecznej — badanie pilotażoweEndokrynologia Polska, 2014
- Comparison of Diagnostic Value of Conventional Ultrasonography and Shear Wave Elastography in the Prediction of Thyroid Lesions MalignancyPLOS ONE, 2013
- Correlation of 18F-FDG PET/CT Findings With Histopathological Results in Differentiated Thyroid Cancer Patients Who Have Increased Thyroglobulin or Antithyroglobulin Antibody Levels and Negative 131I Whole-Body Scan ResultsClinical Nuclear Medicine, 2013
- Increasing the yield of recombinant thyroid-stimulating hormone-stimulated 2-(18-fluoride)-flu-2-deoxy-D-glucose positron emission tomography-CT in patients with differentiated thyroid carcinomaBritish Journal of Radiology, 2012
- 18F-FDG PET/CT changes therapy management in high-risk DTC after first radioiodine therapyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2012
- Clinical Usefulness of Positron Emission Tomography–Computed Tomography in Recurrent Thyroid CarcinomaJAMA Otolaryngology–Head & Neck Surgery, 2010
- Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid CancerThyroid®, 2009
- Outcome of Differentiated Thyroid Cancer with Detectable Serum Tg and Negative Diagnostic 131I Whole Body Scan: Comparison of Patients Treated with High 131I Activities Versus Untreated PatientsThe Journal of Clinical Endocrinology & Metabolism, 2001